CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 10 of 17

Arthritis Research & Therapy

Briefs 361–400 of 641 CurrentRheuma has covered from this journal, newest publication first

Latest from Arthritis Research & Therapy

All coverage, newest first

  1. Arthritis Res Ther

    A phase 3, randomized, double-blind, active-controlled clinical trial to compare BAT1806/BIIB800, a tocilizumab biosimilar, with tocilizumab reference product in participants with moderate-to-severe rheumatoid arthritis with inadequate response to methotrexate: treatment period 2 analysis (week 24 to week 48)

    Randomized controlled trialRA

  2. Arthritis Res Ther

    Factors related to elevated serum immunoglobulin G4 (IgG4) levels in a Japanese general population

    Cross-sectional studyAutoinflammatory & rare

  3. Arthritis Res Ther

    A Bayesian model to analyse the association of comorbidities with biosimilar treatment retention in a non-medical switch scenario in patients with inflammatory rheumatic musculoskeletal diseases

    Cohort studyAcross diseases

  4. Arthritis Res Ther

    Machine learning prediction and explanatory models of serious infections in patients with rheumatoid arthritis treated with tofacitinib

    Secondary analysisRA

  5. Arthritis Res Ther

    Analysis of risk factors and development of a nomogram prediction model for renal tubular acidosis in primary Sjogren syndrome patients

    Cohort studySjögren's & overlap

  6. Arthritis Res Ther

    Association of anti-Ro-52 antibodies with occurrence of interstitial lung disease in patients with idiopathic inflammatory myopathy

    Cohort studyMyositis

  7. Arthritis Res Ther

    Inclusion of fibrinoid necrosis increases the accuracy of synovial tissue assessment in predicting response to methotrexate: analysis of the UCLouvain Brussels ERA Cohort

    Cohort studyRA

  8. Arthritis Res Ther

    Significant overlap of inflammatory and degenerative features on imaging among patients with degenerative disc disease, diffuse idiopathic skeletal hyperostosis and axial spondyloarthritis: a real-life cohort study

    Cross-sectional studySpondyloarthritis & PsA

  9. Arthritis Res Ther

    IL-40 is up-regulated in the synovial fluid and cartilage of osteoarthritis patients and contributes to the alteration of chondrocytes phenotype in vitro

    Mechanistic studyOsteoarthritis

  10. Arthritis Res Ther

    Expression of CD163 and major histocompatibility complex class I as diagnostic markers for idiopathic inflammatory myopathies

    Diagnostic or prognostic studyMyositis

  11. Arthritis Res Ther

    Infrapatellar fat pad size and subcutaneous fat in knee osteoarthritis radiographic progression: data from the osteoarthritis initiative

    Case-control studyOsteoarthritis

  12. Arthritis Res Ther

    Upadacitinib monotherapy versus methotrexate monotherapy in patients with rheumatoid arthritis: efficacy and safety through 5 years in the SELECT-EARLY randomized controlled trial

    Randomized controlled trialRA

  13. Arthritis Res Ther

    Correlation of high-resolution computed tomography and immunological bronchoalveolar lavage in interstitial lung disease at the onset of inflammatory rheumatic diseases: implications for diagnosis and therapeutic strategies

    Cross-sectional studyAcross diseases

  14. Arthritis Res Ther

    Performance of standardized patient reported outcomes developed for spondyloarthritis in primary and concomitant forms of fibromyalgia

    Cohort studySpondyloarthritis & PsA

  15. Arthritis Res Ther

    Predictors of functional improvement and pain reduction in rheumatoid arthritis patients who achieved low disease activity with disease-modifying antirheumatic drugs: a retrospective study of the FIRST Registry

    Cohort studyRA

  16. Arthritis Res Ther

    Elevated neutrophil extracellular traps in systemic sclerosis-associated vasculopathy and suppression by a synthetic prostacyclin analog

    Mechanistic studySystemic sclerosis

  17. Arthritis Res Ther

    Prevalence and location of inflammatory and structural lesions in patients with rheumatoid arthritis and radiographic axial spondyloarthritis with chronic neck pain evaluated by magnetic resonance imaging

    Cross-sectional studyRA

  18. Arthritis Res Ther

    Risk factors of mortality in patients with rheumatoid arthritis-associated interstitial lung disease: a single-centre prospective cohort study

    Cohort studyRA

  19. Arthritis Res Ther

    Effect of ambrisentan in patients with systemic sclerosis and mild pulmonary arterial hypertension: long-term follow-up data from EDITA study

    Randomized controlled trialSystemic sclerosis

  20. Arthritis Res Ther

    JAK inhibitors attenuate hyperactivation of nonswitched memory B cells in rheumatoid arthritis patients in remission

    Mechanistic studyRA

  21. Arthritis Res Ther

    Clinical relevance of positively determined myositis antibodies in rheumatology: a retrospective monocentric analysis

    Cohort studyMyositis

  22. Arthritis Res Ther

    A novel method to monitor rheumatoid arthritis prevalence using hospital and medication databases

    Cross-sectional studyRA

  23. Arthritis Res Ther

    Serum GM-CSF level is a predictor of treatment response to tocilizumab in rheumatoid arthritis patients: a prospective observational cohort study

    Cohort studyRA

  24. Arthritis Res Ther

    The Relationship between the complement system and subclinical carotid atherosclerosis in patients with rheumatoid arthritis

    Cross-sectional studyRA

  25. Arthritis Res Ther

    Investigation of ferroptosis-associated molecular subtypes and immunological characteristics in lupus nephritis based on artificial neural network learning

    Mechanistic studyLupus & APS

  26. Arthritis Res Ther

    S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritis

    Secondary analysisPediatric

  27. Arthritis Res Ther

    The impact of gastroesophageal reflux disease and its treatment on interstitial lung disease outcomes

    Cohort studySystemic sclerosis

  28. Arthritis Res Ther

    Impact of RA treatment strategies on lipids and vascular inflammation in rheumatoid arthritis: a secondary analysis of the TARGET randomized active comparator trial

    Secondary analysisRA

  29. Arthritis Res Ther

    Rituximab in the treatment of progressive interstitial lung disease associated with the antisynthetase syndrome

    Cohort studyMyositis

  30. Arthritis Res Ther

    Phosphoproteomic profiling of early rheumatoid arthritis synovium reveals active signalling pathways and differentiates inflammatory pathotypes

    Mechanistic studyRA

  31. Arthritis Res Ther

    A Phase 1, randomized, double-blind, placebo-controlled, single- and multiple-dose escalation study to evaluate the safety and pharmacokinetics/pharmacodynamics of PF-06835375, a C-X-C chemokine receptor type 5 directed antibody, in patients with systemic lupus erythematosus or rheumatoid arthritis

    Randomized controlled trialLupus & APS

  32. Arthritis Res Ther

    Effectiveness of janus kinase inhibitors in relapsing giant cell arteritis in real-world clinical practice and review of the literature

    Cohort studyVasculitis & PMR

  33. Arthritis Res Ther

    Exploration of the combined role of immune checkpoints and immune cells in the diagnosis and treatment of ankylosing spondylitis: a preliminary study immune checkpoints in ankylosing spondylitis

    Mechanistic studySpondyloarthritis & PsA

  34. Arthritis Res Ther

    Malignancy is increased in patients with antineutrophil cytoplasmic antibody-associated vasculitis in China

    Cohort studyVasculitis & PMR

  35. Arthritis Res Ther

    Predictive models of radiographic progression and pain progression in patients with knee osteoarthritis: data from the FNIH OA biomarkers consortium project

    Case-control studyOsteoarthritis

  36. Arthritis Res Ther

    Microstructural changes of the white matter in systemic lupus erythematosus patients without neuropsychiatric symptoms: a multi-shell diffusion imaging study

    Cross-sectional studyLupus & APS

  37. Arthritis Res Ther

    The prognosis and management of reclassified systemic lupus erythematosus associated pulmonary arterial hypertension according to 2022 ESC/ERS guidelines

    Cohort studyLupus & APS

  38. Arthritis Res Ther

    Investigating protease-mediated peptides of inflammation and tissue remodeling as biomarkers associated with flares in psoriatic arthritis

    Case-control studySpondyloarthritis & PsA

  39. Arthritis Res Ther

    Epidemiological trends in psoriatic arthritis: a comprehensive population-based study

    Cohort studySpondyloarthritis & PsA

  40. Arthritis Res Ther

    Time to improvement of pain, morning stiffness, fatigue, and disease activity in patients with ankylosing spondylitis treated with tofacitinib: a post hoc analysis

    Secondary analysisSpondyloarthritis & PsA

All 641 Briefs in ExploreShowing Briefs 361–400 of 641, newest first